by Lance Smith | Nov 14, 2019 | Study Scavenger Clinical Trial Recruitment Platform
There are numerous steps involved in the clinical trial recruitment process, many of which begin prior to the official “start”. From the planning stages to the conclusion of each trial, the work that must be done is nothing short of extensive. Despite the...by Lance Smith | Nov 14, 2019 | Study Scavenger Clinical Trial Recruitment Platform
Huntington Study Group Announces Initiation of Phase III Clinical Study of Valbenazine for the Treatment of Chorea Associated with Huntington Disease. Rochester, NY, November 14, 2019 –(PR.com)– The Huntington Study Group (HSG), a world leader in...by Lance Smith | Nov 14, 2019 | Study Scavenger Clinical Trial Recruitment Platform
VBI Vaccines (NASDAQ: VBIV) (“VBI”), a commercial-stage biopharmaceutical company developing next-generation infectious disease and immuno-oncology vaccines, and Brii Biosciences (“Brii Bio”), a clinical-stage company committed to serving patients’ needs and improving...by Lance Smith | Nov 12, 2019 | Study Scavenger Clinical Trial Recruitment Platform
– Company Plans to Use Previously Announced Positive Zimura Clinical Trial as One of Two Pivotal Trials – – Zimura R&D Symposium for Investors/Analysts to be Held on November 20, 2019 – – Conference Call and Webcast Today, November...by Lance Smith | Nov 12, 2019 | Study Scavenger Clinical Trial Recruitment Platform
HOUSTON, Nov. 12, 2019 /PRNewswire/ — Soliton, Inc., (SOLY) (“Soliton” or the “Company”), a medical device company with a novel and proprietary platform technology licensed from The University of Texas on behalf of the MD Anderson Cancer...by Lance Smith | Nov 12, 2019 | Study Scavenger Clinical Trial Recruitment Platform
SAN DIEGO, Nov. 12, 2019 (GLOBE NEWSWIRE) — Turning Point Therapeutics, Inc. (NASDAQ: TPTX), a precision oncology company developing novel drugs to address treatment resistance, today announced initiation of a Phase 1/2 clinical study of its lead drug candidate...